Skip links

AACR Annual Meeting, April 14-19, 2023, Orlando, FL, US

Meet with our CTO Alexander Schinagl and CBO Brent Meadows at our two posters entitled: Poster #2974 “Targeting the oxidized form of macrophage migration inhibitory factor (oxMIF) with antibody ON203 activates the tumor microenvironment” and Poster #585 “Pretargeted radioimmunotherapy with a novel anti-oxMIF/HSG bispecific antibody and a 177Lu-loaded HSG radioligand results in significant tumor regression in murine models of cancer”.

Home